Safety and tolerability of caspofungin acetate in the treatment of fungal infections

Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase Inhibitors

Onishi, J. C., Meinz, M., Thompson, J. R., Curotto, J. E., Dreikorn, S., Rosenbach, M. J., Douglas, C. M., Abruzzo, G. K., Flattery, A. M., Kong, L., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.368-377.2000 · Cited by 326 · see citing works

A Randomized Double‐Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis

Villanueva, A., Arathoon, E. G., Gotuzzo, E., Berman, R. S., DiNubile, M. J., & Sable, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323401 · Cited by 308 · see citing works

Current and future antifungal therapy: new targets for antifungal agents

Andriole, V. T. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.151 · Cited by 190 · see citing works

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Hajdu, R., Thompson, R. K., Sundelof, J. G., PELAK, B. A., Bouffard, F. A., Dropinski, J. F., & Kropp, H. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2339 · Cited by 165 · see citing works

Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine

Balani, S. K., Xu, X., Arison, B. H., da Silva, M. V. M., Gries, A., Deluna, F. A., Cui, D., Kari, P. H., Ly, T., Hop, C. E. C. A., et al. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15072-6 · Cited by 102 · see citing works

Guidelines for Treatment of Candidiasis

Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · see citing works

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380 · see citing works

Infection in Organ Transplantation

Fishman, J. A. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14208 · Cited by 814 · see citing works

Aspergillus Infections in Transplant Recipients

Singh, N., & Paterson, D. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.44-69.2005 · Cited by 579 · see citing works

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

Bulpa, P., Dive, A., & Sibille, Y. (2007) · European Respiratory Journal · doi:10.1183/09031936.00062206 · Cited by 465 · see citing works

Echinocandin Antifungal Drugs in Fungal Infections: A Comparison

Chen, S. C.-A., Slavin, M. A., & Sorrell, T. C. (2011) · Drugs · doi:10.2165/11585270-000000000-00000 · Cited by 371 · see citing works

Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients

Maschmeyer, G., Haas, A., & Cornely, O. A. (2007) · Drugs · doi:10.2165/00003495-200767110-00004 · Cited by 366 · see citing works

Caspofungin

Saravolatz, L. D., Deresinski, S. C., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/375080 · Cited by 295 · see citing works

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Walsh, T. J., Adamson, P. C., Seibel, N. L., Flynn, P. M., Neely, M. N., Schwartz, C. L., Shad, A. T., Kaplan, S. L., Roden, M. M., Stone, J. A., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4536-4545.2005 · Cited by 238 · see citing works

Caspofungin: the first representative of a new antifungal class

Letscher‐Bru, V. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg117 · Cited by 235 · see citing works

Management of candidiasis Management of Candida species infections in critically ill patients

Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00831-4 · Cited by 232 · see citing works

Invasive fungal infections in solid organ transplant recipients

Gavaldà, J., Meije, Y., Fortün, J., Roilides, E., Saliba, F., Lortholary, O., Muñóz, P., Grossi, P., & Cuenca‐Estrella, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12660 · Cited by 231 · see citing works

Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration‐Dependent Activity

Wiederhold, N. P., Kontoyiannis, D. P., Chi, J., Prince, R. A., Tam, V. H., & Lewis, R. E. (2004) · The Journal of Infectious Diseases · doi:10.1086/424465 · Cited by 206 · see citing works

Aspergillosis in Solid Organ Transplantation

Singh, N. M., & Husain, S. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12115 · Cited by 201 · see citing works

Comparison of echinocandin antifungals

Eschenauer, G. A., DePestel, D. D., & Carver, P. L. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.1.71 · Cited by 184 · see citing works

Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies

Mattiuzzi, G. N., Alvarado, G. C., Giles, F. J., Ostrosky‐Zeichner, L., Cortes, J. E., O'Brien, S. M., Verstovšek, S., Faderl, S. H., Zhou, X., RAAD, I. I., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.143-147.2006 · Cited by 168 · see citing works

Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases

Nami, S., Aghebati‐Maleki, A., Morovati, H., & Maleki, L. A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.009 · Cited by 162 · see citing works

Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis

Steinbach, W. J., & Stevens, D. A. (2003) · Clinical Infectious Diseases · doi:10.1086/376523 · Cited by 159 · see citing works

Caspofungin: the first in a new class of antifungal agents

Kartsonis, N. A., NIELSEN, J. B. K., & Douglas, C. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00064-5 · Cited by 146 · see citing works

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

Wiederhold, N. P., & Lewis, R. E. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1313 · Cited by 144 · see citing works

Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis

Colombo, A. L., Perfect, J. R., DiNubile, M. J., Bartizal, K. F., Motyl, M. R., Hicks, P. S., Lupinacci, R. J., Sable, C. A., & Kartsonis, N. A. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0973-8 · Cited by 126 · see citing works

The Echinocandins: Comparison of Their Pharmacokinetics, Pharmacodynamics and Clinical Applications

Wagner, C. C., Graninger, W., Presterl, E., & Joukhadar, C. (2006) · Pharmacology · doi:10.1159/000096348 · Cited by 123 · see citing works

Invasive Aspergillosis in Solid Organ Transplant Recipients

Singh, N., & Husain, S. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02910.x · Cited by 123 · see citing works

Fungal Infections

Kauffman, C. A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200510-110jh · Cited by 123 · see citing works

Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A

Marr, K. A., Hachem, R. Y., Papanicolaou, G. A., Somani, J., Arduino, J. M., Lipka, C. J., Ngai, A., Kartsonis, N. A., Chodakewitz, J., & Sable, C. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00065.x · Cited by 117 · see citing works

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014

Chau, M., Kong, D. C. M., van Hal, S. J., Urbancic, K. F., Trubiano, J. A., Cassumbhoy, M., Wilkes, J., Cooper, C. M., Roberts, J. A., Marriott, D. J. E., et al. (2014) · Internal Medicine Journal · doi:10.1111/imj.12600 · Cited by 109 · see citing works

Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine

Dowell, J. A., Stogniew, M., Krause, D., Henkel, T. J., & Weston, I. E. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004270146 · Cited by 106 · see citing works

Potential for Interactions between Caspofungin and Nelfinavir or Rifampin

Stone, J. A., Migoya, E. M., Hickey, L., Winchell, G. A., Deutsch, P., Ghosh, K., Freeman, A., Bi, S., Desai, R., Dilzer, S. C., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4306-4314.2004 · Cited by 99 · see citing works

Concomitant Tacrolimus and Micafungin Pharmacokinetics in Healthy Volunteers

Hébert, M. F., Blough, D. K., Townsend, R. W., Allison, M. J., Buell, D. N., Keirns, J. J., & Bekersky, I. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005279274 · Cited by 93 · see citing works

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

Sanz-Rodrı́guez, C., López‐Duarte, M., Jurado, M., Lopez, J., Arranz, R., Cisneros, J. M., Martino, M. L., García-Sánchez, P., Morales, P., Olivé, T., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704516 · Cited by 84 · see citing works

Current Options in Antifungal Pharmacotherapy

Mohr, J., Johnson, M. D., Cooper, T., Lewis, J. S., & Ostrosky‐Zeichner, L. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.614 · Cited by 85 · see citing works

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

Ullmann, A. J. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001884 · Cited by 84 · see citing works

Fungal infections in solid organ transplantation

Marik, P. E. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.3.297 · Cited by 80 · see citing works

Efficacy of Caspofungin in the Treatment of Esophageal Candidiasis Resistant to Fluconazole

Kartsonis, N., DiNubile, M. J., Bartizal, K., Hicks, P. S., Ryan, D., & Sable, C. A. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200210010-00009 · Cited by 77 · see citing works

Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients

Betts, R. F., Glasmacher, A. G., Maertens, J. A., Maschmeyer, G., Vázquez, J. A., Teppler, H., Taylor, A., Lupinacci, R. J., Sable, C. A., & Kartsonis, N. A. (2005) · Cancer · doi:10.1002/cncr.21615 · Cited by 75 · see citing works

Current status of liver transplantation in children

McDiarmid, S. V. (2003) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(03)00150-0 · Cited by 74 · see citing works

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021

Chau, M., Daveson, K., Alffenaar, J. C., Gwee, A., Ho, S. A., Marriott, D. J. E., Trubiano, J. A., Zhao, J., & Roberts, J. A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15587 · Cited by 74 · see citing works

Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey

Groll, A. H., Attarbaschi, A., Schuster, F. R., Herzog, N., Grigull, L., Dworzak, M. N., Beutel, K., Laws, H., & Lehrnbecher, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl009 · Cited by 70 · see citing works

Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy

Baden, L. R., Katz, J. T., Fishman, J. A., Koziol, C. S., Delvecchio, A., Doran, M., & Rubin, R. H. (2003) · Transplantation · doi:10.1097/01.tp.0000089109.42239.75 · Cited by 69 · see citing works

Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies

Candoni, A., Mestroni, R., Damiani, D., Tiribelli, M., Michelutti, A., Silvestri, F., Castelli, M., Viale, P., & Fanin, R. (2005) · European Journal of Haematology · doi:10.1111/j.1600-0609.2005.00500.x · Cited by 67 · see citing works

Single‐ and Multiple‐Dose Administration of Caspofungin in Patients With Hepatic Insufficiency: Implications for Safety and Dosing Recommendations

Mistry, G. C., Migoya, E. M., Deutsch, P., Winchell, G. A., Hesney, M., Li, S., Bi, S., Dilzer, S. C., Lasseter, K. C., & Stone, J. A. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007303764 · Cited by 64 · see citing works

Micafungin: A New Echinocandin Antifungal

Joseph, J., Jain, R., & Danziger, L. H. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.53 · Cited by 63 · see citing works

Lack of Pharmacokinetic Interaction Between Anidulafungin and Tacrolimus

Dowell, J. A., Stogniew, M., Krause, D., Henkel, T. J., & Damle, B. D. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006296764 · Cited by 65 · see citing works

Caspofungin as First-Line Therapy for the Treatment of Invasive Aspergillosis After Thoracic Organ Transplantation

Groetzner, J., Kaczmarek, I., Wittwer, T., Strauch, J., Meiser, B., Wahlers, T., Daebritz, S. H., & Reichart, B. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.10.002 · Cited by 63 · see citing works

Empirical antifungal therapy

Klastersky, J. A. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.002 · Cited by 58 · see citing works

Antifungal Agents in Children

Steinbach, W. J. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.02.009 · Cited by 59 · see citing works

Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis

Imai, J. K., Singh, G., Clemons, K. V., & Stevens, D. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.4063-4066.2004 · Cited by 59 · see citing works

Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis

Cesaro, S., Toffolutti, T., Messina, C., Calore, E., Alaggio, R., Cusinato, R., Pillon, M., & Zanesco, L. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00254.x · Cited by 55 · see citing works

Echinocandins in the management of invasive fungal infections, part 2

Morris, M. I., & Villmann, M. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050464.p2 · Cited by 54 · see citing works

The first echinocandin: caspofungin

Cornely, O. A., Schmitz, K., & Aisenbrey, S. (2002) · Mycoses · doi:10.1111/j.1439-0507.2002.tb04771.x · Cited by 53 · see citing works

Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp. y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011

Fortün, J., Carratalà, J., Gavaldà, J., Lizasoaín, M., Salavert, M., de la Cámara, R., Borges-Sa, M., Cervera, C., Garnacho, J., Lassaleta, Á., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.01.010 · Cited by 52 · see citing works

Invasive candidiasis in cancer patients: observations from a randomized clinical trial

DiNubile, M. J., Hille, D. A., Sable, C. A., & Kartsonis, N. A. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.01.016 · Cited by 53 · see citing works

Efficacy and mechanism of actions of natural antimicrobial drugs

Ye, L., Zhang, J., Xiao, W. L., & Liu, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107671 · Cited by 51 · see citing works

Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis

van Vianen, W., de Marie, S., ten Kate, M. T., Mathôt, R. A. A., & Bakker‐Woudenberg, I. A. J. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl015 · Cited by 51 · see citing works

Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high‐risk liver transplantation recipients: A propensity score analysis

Fortün, J., Muriel, A., Martín‐Dávila, P., Montejo, M., Len, Ó., Torre‐Cisneros, J., Carratalà, J., Muñóz, P., Fariñas, M. C., Moreno, A., et al. (2015) · Liver Transplantation · doi:10.1002/lt.24391 · Cited by 51 · see citing works

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection

de Fabritiis, P., Spagnoli, A., Bartolomeo, P. D., Locasciulli, A., Cudillo, L., Milone, G., Busca, A., Picardi, A., Scimè, R., Bonini, A., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705720 · Cited by 49 · see citing works

Disposition of Caspofungin, a Novel Antifungal Agent, in Mice, Rats, Rabbits, and Monkeys

Sandhu, P., Xu, X., Bondiskey, P. J., Balani, S. K., Morris, M. L., Tang, Y. S., Miller, A. R., & Pearson, P. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1272-1280.2004 · Cited by 49 · see citing works

Emerging echinocandins for treatment of invasive fungal infections

Turner, M., Drew, R. H., & Perfect, J. R. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.2.231 · Cited by 49 · see citing works

Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high‐risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy

SAFDAR, A. Y. E. S. H. A., Papadopoulos, E. B., & Young, J. W. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.02008.x · Cited by 48 · see citing works

Aspergilosis. Formas clínicas y tratamiento

Fortün, J., Meije, Y., Fresco, G., & Moreno, S. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.12.005 · Cited by 49 · see citing works

Invasive candidiasis treated in the intensive care unit: Observations from a randomized clinical trial

DiNubile, M. J., Lupinacci, R. J., Strohmaier, K. M., Sable, C. A., & Kartsonis, N. A. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.11.004 · Cited by 46 · see citing works

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature

Glöckner, A. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-4-167 · Cited by 46 · see citing works

Antifungal treatment in pediatric patients

Zaoutis, T. E., Benjamin, D. K., & Steinbach, W. J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.06.005 · Cited by 43 · see citing works

Response and Relapse Rates of Candidal Esophagitis in HIV-Infected Patients Treated with Caspofungin

DiNubile, M. J., Lupinacci, R. J., Berman, R. S., & Sable, C. A. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/088922202760265579 · Cited by 42 · see citing works

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation

Trenschel, R., Ditschkowski, M., Elmaagacli, A. H., Koldehoff, M., Ottinger, H., Steckel, N. K., Hlinka, M., Peceny, R., Rath, P., Dermoumi, H. L., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704859 · Cited by 40 · see citing works

SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS

Zaoutis, T. E., Lehrnbecher, T., Groll, A. H., Steinbach, W. J., Jafri, H. S., Maertens, J. A., Ngai, A. L., Chow, J. W., Taylor, A. F., Strohmaier, K. M., et al. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181af5a15 · Cited by 37 · see citing works

Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients

Li, C., Sun, P. G., Dong, Y., Bi, S., Desai, R., Dockendorf, M. F., Kartsonis, N. A., Ngai, A. L., Bradshaw, S. K., & Stone, J. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00905-10 · Cited by 36 · see citing works

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients

Hamza, N. S., Ghannoum, M. A., & Lazarus, H. M. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704603 · Cited by 36 · see citing works

Successful antifungal combination therapy with voriconazole and caspofungin

Schuster, F. R., Moelter, C., Schmid, I., Graubner, U. B., Kammer, B., Belohradsky, B. H., & Führer, M. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20302 · Cited by 33 · see citing works

Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants

Migoya, E. M., Mistry, G. C., Stone, J. A., Comisar, W. A., Sun, P. G., Norcross, A., Bi, S., Winchell, G. A., Ghosh, K., Uemera, N., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010374853 · Cited by 31 · see citing works

Pediatric antifungal agents

Cohen‐Wolkowiez, M., Moran, C., Benjamin, D. K., & Smith, P. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283321ccc · Cited by 30 · see citing works

Recent advances in antifungal pharmacotherapy for invasive fungal infections

Gallagher, J. C., MacDougall, C., Ashley, E. S. D., & Perfect, J. R. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.2.253 · Cited by 30 · see citing works

Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model

Imai, J. K., Singh, G., Fernández, B., Clemons, K. V., & Stevens, D. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki178 · Cited by 30 · see citing works

Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials

Falagas, M. E., Ntziora, F., Betsi, G. I., & Samonis, G. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.09.018 · Cited by 28 · see citing works

Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report

Ngai, A. L., Bourque, M. R., Lupinacci, R. J., Strohmaier, K. M., & Kartsonis, N. A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.07.008 · Cited by 27 · see citing works

Clinical Pharmacology of Anti-Infective Drugs

Wade, K. C., & Benjamin, D. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00037-7 · Cited by 26 · see citing works

Defining Targets for Investigating the Pharmacogenomics of Adverse Drug Reactions to Antifungal Agents

Meletiadis, J., Chanock, S. J., & Walsh, T. J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.561 · Cited by 26 · see citing works

The Use of Antifungal Therapy in Neonatal Intensive Care

Testoni, D., Smith, P. B., & Benjamin, D. K. (2012) · Clinics in Perinatology · doi:10.1016/j.clp.2011.12.008 · Cited by 24 · see citing works

Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A

Morrissey, C. O., Slavin, M. A., O’Reilly, M., Daffy, J. R., Seymour, J. F., Schwarer, A. P., & Szer, J. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01377.x · Cited by 24 · see citing works

The use of caspofungin in HIV-infected individuals

Waters, L. J., & Nelson, M. R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.899 · Cited by 23 · see citing works

Clinical pharmacology of antifungal agents in pediatric patients

Chiou, C. C., Walsh, T. J., & Groll, A. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.15.2465 · Cited by 22 · see citing works

Antifungal activities of tacrolimus in combination with antifungal agents against fluconazole-susceptible and fluconazole-resistant Trichosporon asahii isolates

Kubiça, T. F., Denardi, L. B., de Azevedo, M. I., Oliveira, V., Severo, L. C., Santúrio, J. M., & Alves, S. H. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2016.08.008 · Cited by 21 · see citing works

Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

Yeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20 · see citing works

Treatment of Candidal Cholangitis with Caspofungin Therapy in a Patient with a Liver Transplant: Documentation of Biliary Excretion of Caspofungin

Goicoechea, M., Fierer, J., & Johns, S. T. (2004) · Clinical Infectious Diseases · doi:10.1086/382082 · Cited by 20 · see citing works

An advanced double column‐switching technique (LC‐LC) for liquid chromatography/electrospray ionisation tandem mass spectrometry for fully automated analysis of caspofungin

Egle, H., Trittler, R., & Kümmerer, K. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1691 · Cited by 20 · see citing works

Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells

Wegner, B., Baer, P. C., Gauer, S., Oremek, G. M., Hauser, I. A., & Geiger, H. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh948 · Cited by 18 · see citing works

Antifungal prophylaxis in lung transplantation

Neoh, C. F., Snell, G. I., Levvey, B. J., Morrissey, C. O., Stewart, K., & Kong, D. C. M. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.013 · Cited by 18 · see citing works

Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento

Cervera, C. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.02.003 · Cited by 32 · see citing works

Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant Klebsiella pneumoniae

Hussein, M. H., Wong, L. J. M., Zhao, J., Rees, V. E., Allobawi, R., Sharma, R., Rao, G. G., Baker, M. A., Li, J., & Velkov, T. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.02.021 · Cited by 14 · see citing works

Physiology-Based Pharmacokinetics of Caspofungin for Adults and Paediatrics

Stader, F., Würthwein, G., Groll, A. H., Vehreschild, J. J., Cornely, O. A., & Hempel, G. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1595-9 · Cited by 15 · see citing works

Caspofungin for invasive fungal infections: Combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation

Pancham, S., Hemmaway, C. J., New, H. V., Albert, E., Dokal, I. S., Roberts, I. A. G., & McCloy, M. (2005) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2005.00261.x · Cited by 15 · see citing works

Co-administration of Caspofungin and Cyclosporine to a Kidney Transplant Patient with Pulmonary Aspergillus Infection

Anttila, V.-J., Piilonen, A. K., & Valtonen, M. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016871 · Cited by 15 · see citing works

Immunosuppressive drug interactions with anti-infective agents

(2004) · American Journal of Transplantation · doi:10.1111/j.1600-6135.2004.00738.x · Cited by 15 · see citing works

La caspofungine : du mécanisme d'action aux applications thérapeutiques

Datry, A., & Bart–Delabesse, E. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.05.012 · Cited by 14 · see citing works

Safety and Potential of Drug Interactions of Caspofungin and Voriconazole in Multimorbid Patients

Kulemann, V., Bauer, M., Graninger, W., & Joukhadar, C. (2005) · Pharmacology · doi:10.1159/000088622 · Cited by 14 · see citing works

Efficacies of caspofungin and a combination of caspofungin and meropenem in the treatment of murine disseminated candidiasis

Özcan, S. K., Budak, F., Willke, A., Filiz, S., Costur, P., & Dalçık, H. (2006) · Apmis · doi:10.1111/j.1600-0463.2006.apm_450.x · Cited by 13 · see citing works

Recommendations for the treatment of fungal pneumonias

Yamada, H., Kotaki, H., & Takahashi, T. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.8.1241 · Cited by 12 · see citing works

Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation

Nishimoto, M., Koh, H., Tokuwame, A., Makuuchi, Y., Kuno, M., Takakuwa, T., Okamura, H., Koh, S., Yoshimura, T., Nanno, S., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13303 · Cited by 12 · see citing works

Les échinocandines : une nouvelle classe d’antifongiques

Lacroix, C., Machouart, M., & de Chauvin, M. F. (2003) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(03)00059-3 · Cited by 10 · see citing works

Modern management of respiratory failure due to pulmonary mycoses following allogeneic hematopoietic stem‐cell transplantation

Koldehoff, M., & Zakrzewski, J. L. (2005) · American Journal of Hematology · doi:10.1002/ajh.20361 · Cited by 10 · see citing works

Caspofungin: the first in a new class of antifungal agents

Kartsonis, N. A., NIELSEN, J. B. K., & Douglas, C. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00064-5 · Cited by 146 · see citing works

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

Sanz-Rodrı́guez, C., López‐Duarte, M., Jurado, M., Lopez, J., Arranz, R., Cisneros, J. M., Martino, M. L., García-Sánchez, P., Morales, P., Olivé, T., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704516 · Cited by 84 · see citing works

Caspofungin Acetate for Treatment of Invasive Fungal Infections

Pacetti, S., & Gelone, S. P. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c114 · Cited by 47 · see citing works

Caspofungin acetate: An antifungal agent

Hoang, A. D. (2001) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/58.13.1206 · Cited by 68 · see citing works

Caspofungin: first approved agent in a new class of antifungals

Johnson, M. D., & Perfect, J. R. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.5.807 · Cited by 85 · see citing works